By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Hologic announced after the close of the market on Thursday that it has received regulatory approval in the US of its automated system for use with the company's human papillomavirus test.

The approval from the US Food and Drug Administration is for the Cervista HTA high-throughput automation system to be used with Hologic's Cervista HPV HR test, which was approved by the agency in 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.